Pasithea Therapeutics Cor...

1.13
-0.03 (-2.59%)
At close: Mar 03, 2025, 3:59 PM
1.07
-4.89%
After-hours: Mar 03, 2025, 06:59 PM EST

Pasithea Therapeutics Balance Sheet Statement

Year FY23 FY22 FY21 FY20
Cash & Equivalents 16.33M 33.15M 52.97M 243.65K
Short-Term Investments n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a
Other Long-Term Assets n/a -11.1M -20.12K n/a
Receivables 40.5K n/a n/a n/a
Inventory -40.5K 1.00 n/a n/a
Other Current Assets 361.1K 988.83K 333.75K 4.31K
Total Current Assets 16.69M 34.08M 53.3M 247.96K
Property-Plant & Equipment 220.48K 1.25M 20.12K n/a
Goodwill & Intangibles 9.2M 9.85M n/a n/a
Total Long-Term Assets 9.42M 11.1M 20.12K n/a
Total Assets 26.12M 45.18M 53.32M 247.96K
Account Payables 2.55M 1.48M 447.28K 6.6K
Deferred Revenue n/a -1.61M n/a n/a
Short-Term Debt 81.68K 160.36K n/a n/a
Other Current Liabilities n/a 235.88K n/a n/a
Total Current Liabilities 2.63M 1.88M 447.28K 6.6K
Long-Term Debt n/a 344.02K n/a n/a
Other Long-Term Liabilities 84.37K 460.19K 1.45M n/a
Total Long-Term Liabilities 84.37K 804.21K 1.45M n/a
Total Liabilities 2.72M 2.68M 1.9M 6.6K
Total Debt 81.68K 926.89K n/a n/a
Common Stock 104.00 17.99K 17.68K 14.94K
Retained Earnings -35.32M -19.36M -2.21M -40.98K
Comprehensive Income -4.65K -661 -10.56K -0.00
Shareholders Equity 23.4M 42.5M 51.42M 241.35K
Total Investments n/a n/a n/a n/a